Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease (Q28220999)

European Journal of Clinical Investigation

Europe PubMed Central

title

Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease (English)

0 references

1 reference

A Blinc

1

0 references

P Poredos

series ordinal

2

0 references

language of work or name

English

0 references

publication date

March 2007

0 references

published in

0 references

volume

37

0 references

issue

3

0 references

page(s)

157-64

0 references

cites work

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.2007.01767.X

Aspirin and clopidogrel resistance: an emerging clinical entity

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.2007.01767.X

Aspirin resistance: position paper of the Working Group on Aspirin Resistance

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.2007.01767.X

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.2007.01767.X

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.2007.01767.X

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.2007.01767.X

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.2007.01767.X

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.2007.01767.X

Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.2007.01767.X

Homocysteine lowering and cardiovascular events after acute myocardial infarction

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.2007.01767.X

Homocysteine lowering with folic acid and B vitamins in vascular disease

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.2007.01767.X

Peripheral arterial disease detection, awareness, and treatment in primary care

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.2007.01767.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.2007.01767.X

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.2007.01767.X

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Mortality over four years in SHEP participants with a low ankle-arm index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Bezafibrate in men with lower extremity arterial disease: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Effects of colestipol-niacin therapy on human femoral atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Beta-blockers in heart failure: are pharmacological differences clinically important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Nebivolol: a review of its clinical and pharmacological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Ramipril: a review of its use in the prevention of cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Improving foot care for people with diabetes mellitus--a randomized controlled trial of an integrated care approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X

Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2007.01767.X